Healthcare Finance News July 30, 2020
The proposals, made during a global pandemic, will likely have little political support and may stifle innovation, experts say.
Recently, President Trump proposed four different executive orders aimed at lowering drug prices in a move that some see as calculated to secure votes from seniors in the run-up to November’s presidential election. There’s no doubt that drug prices have become a challenge for many Americans, but as finer details of the executive orders have yet to emerge, it’s unclear whether they would have the intended effect if enacted.
The broad strokes are there. One proposed executive order would eliminate rebates from drug companies that go to pharmacy benefit managers, the middlemen who negotiate with drug companies on behalf of insurers....
Today's Sponsors
Today's Sponsor